跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 92,224 条关于
“thyroid disease”
全部
92,224
临床试验
69,441
药物
1,456
机构
169
资讯
21,158
4年前
Teprotumumab (Tepezza) Approved for Thyroid Eye Disease Treatment
5个月前
Immunovant's Batoclimab Fails Phase 3 Thyroid Eye Disease Trials Despite Early Promise
去年
Acelyrin's Lonigutamab Shows Promise in Thyroid Eye Disease Phase 2 Data
9个月前
GenSci Partners with RTW Investments in $1.365 Billion Deal for First-in-Class Thyroid Autoimmune Disease Therapy
2年前
Acelyrin Shifts Focus to Thyroid Eye Disease Drug, Halts Further Investment in Izokibep
去年
Acelyrin's Lonigutamab Shows Promise in Phase 2 Data for Thyroid Eye Disease
5个月前
Amgen's Subcutaneous TEPEZZA Shows 77% Response Rate in Phase 3 Thyroid Eye Disease Trial
去年
EMA Recommends Approval of Tepezza for Thyroid Eye Disease, First Targeted Treatment in EU
9个月前
argenx Discontinues Phase 3 UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease Following Futility Analysis
去年
China Approves SYCUME®: First IGF-1R Antibody for Thyroid Eye Disease in 70 Years
第 1 页,共 2116 页
上一页
下一页